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Abstract
The extracellular matrix (ECM) plays a vital role in maintaining normal tissue function. Colla-
gens are major components of the ECM and there is a tight equilibrium between degradation
and formation of these proteins ensuring tissue health and homeostasis. As a consequence
of tissue turnover, small collagen fragments are released into the circulation, which act as
important biomarkers in the study of certain tissue-related remodeling factors in health and
disease. The aim of this study was to establish an age-related collagen turnover profile of
the main collagens of the interstitial matrix (type I and III collagen) and basement membrane
(type IV collagen) in healthy men and women.
By using well-characterized competitive ELISA-assays, we assessed specific fragments
of degraded (C1M, C3M, C4M) and formed (PINP, Pro-C3, P4NP7S) type I, III and IV colla-
gen in serum from 617 healthy men and women ranging in ages from 22 to 86. Subjects
were divided into 5-year age groups according to their sex and age. Groups were compared
using Kruskal-Wallis adjusted for Dunn’s multiple comparisons test and Mann-Whitney t-
test. Age-specific changes in collagen turnover was most profound for type I collagen. PINP
levels decreased in men with advancing age, whereas in women, the level decreased in
early adulthood followed by an increase around the age of menopause (age 40–60). Sex-
specific changes in type I, III and IV collagen turnover was present at the age around meno-
pause (age 40–60) with women having an increased turnover. In summary, collagen turn-
over is affected by age and sex with the interstitial matrix and the basement membrane
being differently regulated. The observed changes needs to be accounted for when measur-
ing ECM related biomarkers in clinical studies.
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Introduction
The extracellular matrix (ECM) is the backbone of all tissues. It is composed of several struc-
tural proteins, including collagens, which play a vital role for the function and maintenance of
normal tissue function. Collagen type I and III are the most abundant collagens of the intersti-
tial matrix and essential for its structure. The basement membrane, underlying epithelial or
endothelial cells, primarily consist of collagen type IV which ensure optimal cell polarization
and function [1,2].
ECM tissue turnover, i.e. the tight balance between protein degradation and formation can
be classified as two processes: 1) tissue modeling, occurring during development and growth
where new tissue is being generated; 2) tissue remodeling, where functional tissue is being
maintained by replacing old and damaged proteins with new ones [3,4]. Every healthy organ is
undergoing continuous remodeling with a tight control between degradation and formation.
However, this delicate balance might be disturbed, leading to connective tissue disorders such
as fibrosis and cancer [5]. Measurements of ECM turnover products in blood have shown that
circulating components of the ECM, especially collagens, are elevated in fibrotic diseases [6–
10] and cancer [11,12]. We have developed a panel of serum-based assays specifically measur-
ing collagen fragments that reflect either degradation or formation separately [13–18]. The
principle behind these assays is the use of monoclonal antibodies exclusively reacting with a
specific fragment of a certain protein which become exposed after specific protease-mediated
degradation. Antibodies raised against pro-peptides of pro-collagens reflect collagen formation
whereas antibodies recognizing small neo-epitopes on peptides derived from collagen degra-
dation of the triple helical region represent collagen degradation [5,19,20]. Table 1 summarizes
the assays we have used in this study and which ECM process they represent.
PINP, which measures the N-terminal pro-peptide released during collagen formation,
have been showed to primarily reflect synthesis of bone matrix [21]. C1M, which measures
a MMP-degraded fragment of type I collagen released during tissue remodeling, is closely
related to chronic inflammation with high levels being present in various inflammatory dis-
eases [14,22–25]. Pro-C3 measures the pro-peptide of type III collagen, i.e. synthesis, and C3M
measures a MMP-generated type III collagen fragment, i.e. degradation. Increased levels of
Pro-C3 and C3M have also been linked to inflammatory diseases and especially fibrosis [25–
30]. P4NP7S, which reflects type IV collagen formation by measuring the 7S domain of type
IV collagen, has been associated with fibrosis of the liver [31] and C4M, which reflects MMP-
mediated degradation of the basement membrane, is elevated in patients with diseases display-
ing chronic inflammation [18,24,32–34].
While it has been shown that levels of ECM proteins vary significantly with age [35–39], a
collagen turnover profile in men and women of varying age using a well-defined panel of
markers directly measuring degradation and formation of interstitial matrix and basement
membrane collagens has never been publihsed. In this study, we investigated age- and sex-
Table 1. Description of the collagen degradation and formation assays used in this study.
Biomarker Specification Process Surrogate measure
C1M[14] Neo-epitope of MMP-2,9,13 mediated degradation of type I collagen Type I collagen degradation Chronic inflammation
PINP[13] Internal epitope in the N-terminal pro-peptide of type I collagen Type I collagen formation Primarily bone synthesis
C3M[16] Neo-epitope of MMP-9 mediated degradation of type III collagen Type III collagen degradation Chronic inflammation
Pro-C3[15] Released N-terminal pro-peptide of type III collagen Type III collagen formation Fibrosis
C4M[18] Neo-epitope of MMP-2,9,12 mediated degradation of type IV collagen alpha 1 Type IV collagen degradation Chronic inflammation
P4NP7S[17] Internal epitope in the 7S domain of type IV collagen Type IV collagen formation Fibrosis
https://doi.org/10.1371/journal.pone.0194458.t001
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dependent ECM turnover as function of age in healthy men and women by measuring bio-
markers of formation and degradation of the most abundant collagens of the interstitial matrix
(collagen type I and III) and basement membrane (collagen type IV) in serum.
Materials and methods
Serum samples
The serum samples used in this study originated from a population-based cross-sectional
study where subjects were recruited in 2007–2011 from a random sample of all districts in Ber-
lin provided by the resident registration office. A total number of 617 subjects, comprising 303
healthy men and 314 healthy women aged 22–86, were included in this study. Characteristics
of the study population are presented in Table 2.
Venous blood samples were collected by trained medical technologists between 08:00 and
10:00 AM after a 12 h fasting period. 30 min. after blood drawing, samples were centrifuged at
3500 rpm for 10 min, serum was obtained and samples were stored at -80˚C until analysis.
The study was approved by the local ethics committee (Ethikkommission der Charite´,
Charite´ –Universita¨tsmedizin Berlin, EA4/095/05) as well as the German Radiation Protection
Ordinance (Z5-22462/2-2005-063). Written informed consent was obtained from all partici-
pants before they were included into the study and the study was carried out in accordance
with ICH-GCP and according to the Declaration of Helsinki.
Collagen turnover biomarker analysis
All biomarker assays were manufactured by Nordic Bioscience (Herlev Denmark) and per-
formed according to the manufacturer’s specifications. The assays are competitive ELISA’s
which have been thoroughly validated for their use in human serum samples and technically
characterized with regards to linearity, accuracy and reproducibility (the original assay refer-
ence for each biomarker is listed in Table 1). To eliminate/reduce inter-assay variation, all
biochemical markers were measured using a single lot of reagents and serum controls were
included on each plate. Females and males, as well as age-groups were randomly distributed
on the different ELISA plates. All samples were analyzed by a CAP/CLIA-accredited laboratory
(Nordic Bioscience Laboratory, Herlev, Denmark).
The neo-epitope biomarkers of matrix metalloproteinase (MMP) degraded type I, type III
and type IV collagen (C1M, C3M, C4M) and type I, type III and type IV collagen formation
products (PINP, Pro-C3, P4NP7S) were assessed in serum as previously described [13–18].
Briefly, 96-well pre-coated streptavidin plates were coated with biotinylated synthetic peptides
specific for the protein of interest and incubated for 30 minutes at 20˚C. 20 μL of standard pep-
tide or pre-diluted serum sample were added to designated wells followed by the addition of
peroxidase-conjugated specific monoclonal antibodies and incubated for 1 h at 20˚C or over-
night at 4˚C. Finally, tetramethylbenzinidine (TMB) (cat. 438OH, Kem-En-Tec Diagnostics,
Denmark) was added to each well and the plates were incubated for 15 minutes at 20˚C. All
incubation steps included shaking at 300 rpm and after each incubation step, the plates were
washed five times with wash buffer (20 mM Tris, 50 mM NaCl, pH 7.2). The enzymatic reac-
tion was stopped by adding 0.18 M H2SO4 and absorbance was measured at 450 nm with 650
nm as reference. A calibration curve was plotted using a 4-parameter logistic curve fit.
Statistical analysis
Subjects were stratified into 5-year interval age groups. To investigate if the biomarkers
changed with age, the levels of the individual biomarkers in each 5-year age group were
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Table 2. Basal characteristics of the study population.
Men (n = 303)
Age group Age (median, years)
Range (min.-max.)
Weight (median, kg)
Range (min.-max.)
Height (median, cm)
Range (min.-max.)
BMI (median, kg/m2)
Range (min.-max.)
20–24 (n = 19) 24
22–24
75
58–128
181
170–197
23.1
19.8-37-4
25–29 (n = 25) 26
25–29
76
61–104
179
168–202
23.8
20.5–30.0
30–34 (n = 24) 31
30–34
78
64–120
178
164–189
24.7
18.7–35.8
35–39 (n = 24) 36
35–37
83
64–120
180
167–193
26.1
19.0–38.0
40–44 (n = 21) 43
40–44
87
53–122
179
164–195
26.5
19.7–36.4
45–49 (n = 18) 48
45–49
85
69–101
178
169–199
26.2
22.0–30.4
50–54 (n = 24) 52
50–54
83
57–106
181
171–188
25.5
17.1–32.4
55–59 (n = 28) 57
55–59
54
57–101
177
159–192
27.0
20.7–34.5
60–64 (n = 23) 63
60–64
82
70–109
176
166–197
26.1
22.9–34.9
65–69 (n = 30) 67
65–69
83
50–126
172
161–183
27.1
17.8–38.7
70–74 (n = 20) 72
70–74
84
67–102
175
158–184
29.0
22.2–33.6
75–79 (n = 17) 79
77–79
77
60–118
169
159–183
27.0
23.9–36.4
80+ (n = 30) 82
80–86
78
52–99
175
161–182
25.8
16.1–30.8
Women (n = 314)
Age group Age (median, years)
Range (min.-max.)
Weight (median, kg)
Range (min.-max.)
Height (median, cm)
Range (min.-max.)
BMI (median, kg/m2)
Range (min.-max.)
20–24 (n = 12) 23
22–24
63
48–105
173
158–184
21.7
18.6–33.1
25–29 (n = 29) 26
25–29
62
52–74
166
157–180
21.4
18.5–27.9
30–34 (n = 22) 32
30–34
65
46–90
168
154–186
22.2
19.4–31.9
35–39 (n = 25) 36
35–37
72
51–93
164
155–185
25.1
18.8–34.0
40–44 (n = 26) 43
40–44
69
50–89
168
157–183
23.7
17.7–33.6
45–49 (n = 24) 48
45–49
76
51–95
166
146–180
26.8
18.5–36.1
50–54 (n = 25) 52
50–54
66
52–104
165
156–173
23.1
20.8–36.4
55–59 (n = 26) 57
55–59
66
50–87
163
155–175
25.4
19.1–32.0
60–64 (n = 32) 62
60–64
67
53–109
161
154–172
26.1
20.5–38.9
65–69 (n = 29) 67
65–69
64
47–97
161
152–171
24.9
19.2–33.6
70–74 (n = 20) 72
70–74
69
53–79
159
146–175
27.0
21.6–31.7
(Continued)
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compared using a Kruskal—Wallis ANOVA (S1 Table). The p-values were adjusted to account
for multiple comparisons using Dunnett´s method. An increase or decrease is defined as a sig-
nificant difference between two following age groups, e.g. age group 25–29 vs. 30–34 (two
adjacent age groups).
To investigate if the biomarkers varied according to sex, the level of the individual bio-
markers between men and women in the five-year age groups was compared using the
Mann-Whitney test. Serum biomarker data can be found in S1 Data. Graph design and sta-
tistical analyses were performed using GraphPad Prism version 7.03 (GraphPad Software,
Inc., CA, USA).
Results
Age specific changes in collagen remodeling
Type I collagen. Type I collagen formation and degradation were measured with the
PINP and C1M assays, respectively. In men, the highest level of PINP was found at age 20–24
(Fig 1A).
The level declined with increasing age. Comparing the level at age 20–24 with the rest of the
age-groups, a significant decrease was observed from age 45–49 to 80+ (S1 Table). In women,
the highest level of PINP was found at age 20–24 and 80+. PINP levels decreased from age 20–
24 until age 35–39, but not significantly (Fig 1A). Around menopause (average age 40–60 [40])
the level significantly increased until age 60–64 (S1 Table).
The level of C1M in men was relatively stable with no significant changes (Fig 1B). The
level of C1M in women was also relatively stable with only a significant increase between age
group 40–44 and 70–74 (Fig 1B) (S1 Table).
Table 2. (Continued)
75–79 (n = 21) 78
75–79
70
56–108
160
147–171
26.5
21.7–38.3
80+ (n = 23) 81
80–86
64
46–79
159
147–177
25.3
20.1–31.7
https://doi.org/10.1371/journal.pone.0194458.t002
Fig 1. Type I collagen turnover as function of age. Biomarkers reflecting degradation and formation of type I collagen were measured in serum
from 303 healthy men and 314 healthy women aged 22–86 divided into 5-year age groups. (A) Formation of interstitial type I collagen (PINP)
and (B) degradation of interstitial type I collagen (C1M). Statistical significance of C1M and PINP between each age group was calculated using
ANOVA comparing the mean of each group with the mean of every other group and is presented at the different age groups in S1 Table. All data
are shown as median and interquartile range.
https://doi.org/10.1371/journal.pone.0194458.g001
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Type III collagen. The ELISA assays Pro-C3 and C3M were used to measure type III col-
lagen formation and degradation, respectively. Pro-C3 levels in men showed a significant
decrease between age 20–24 and 45–49 followed by a significant increase until age 80+ (Fig
2A) (S1 Table).
The level of Pro-C3 was relatively stable in women with no significant changes until age
45–49. A significant increase from age 45–49 and 55–59 until age 80+ was observed (Fig 2A)
(S1 Table).
The level of C3M in men was relatively stable from age 20–80+ with no significant changes
(Fig 2B). The same pattern was seen in women (Fig 2B). However, around menopause (average
age 40–60 [40]) the level significantly increased until age 55–59 (S1 Table) followed by a steep
significant decline (S1 Table).
Type IV collagen. Type IV collagen formation and degradation were measured with the
P4NP7S and C4M assays, respectively. The level of P4NP7S in men and women was relatively
stable with no significant changes across the age span (Fig 3A).
The same pattern was observed with C4M in men (Fig 3B). In women, a significant increase
was observed from age 25–29 reaching a maximum at age 55–59 (Fig 1F) (S1 Table). The level
significantly decreased reaching its starting level at age 80+ (S1 Table).
Sex specific changes in collagen remodeling
Type I collagen. For PINP, the starting level was significantly higher in men compared to
women until the age of 45–49 (Table 3).
Around this age, the level starts to increase in women, whereas the level in men continues
to decrease. In the postmenopausal period (age 60–80+), the level was significantly higher in
women compared to men, except at the age of 70–79 (Table 3).
For C1M, no significant difference between the sexes was observed.
Type III collagen. The level of Pro-C3 was significantly different in women compared to
men in specific age groups in the end of the menopausal period (age 55–59) and the postmeno-
pausal period (70–74 and 75–79) with men having the highest level (Table 3).
For C3M, a significantly higher level was observed in women as compared to men at the
age of 55–59 (menopausal period) (Table 3).
Fig 2. Type III collagen turnover as function of age. Biomarkers reflecting degradation and formation of type III collagen were measured in
serum from 303 healthy men and 314 healthy women aged 22–86 divided into 5-year age groups. (A) Formation of interstitial type III collagen
(Pro-C3) and (B) degradation of interstitial type III collagen (C3M). Statistical significance of C3M and Pro-C3 between each age group was
calculated using ANOVA comparing the mean of each group with the mean of every other group and is presented at the different age groups in S1
Table. All data are shown as median and interquartile range.
https://doi.org/10.1371/journal.pone.0194458.g002
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Type IV collagen. As with C3M, a significantly higher level of P4NP7S in women at age
55–59 was observed (Table 3). The level of C4M was significant different in men and women
at age 20–24 and 55–59 with women having the highest level (Table 3).
Discussion
The present study defines a collagen turnover profile of the main collagens of the interstitial
matrix (type I and III collagen) and basement membrane (type IV collagen) as function of age
in healthy men and women. The main findings of the study were: 1) age specific changes in
collagen turnover was most profound for type I collagen with its formation being strongly age-
dependent and 2) sex specific changes in collagen turnover was most apparent during the
menopausal and post-menopausal periods with the interstitial matrix and basement mem-
brane being differently regulated. To our knowledge, this is the first time a collagen turnover
profile measuring collagen formation and degradation separately, has been established in
healthy men and women across the age span of adults.
Type I collagen is the main ECM component of bone, composing 90% of the organic matrix
[41] and its formation seems to be strongly age-dependent (Fig 1A). The level of PINP was
higher in young men and women compared to older subjects with a progressive decrease until
the age around 50. This observation is in accordance with previous studies showing a decrease
in women between age 30–35, stable level from age 35–45 followed by an increase until the age
of 65 [35,37]. In men, a significant decrease with age has also been observed [37]. The decline
in PINP levels until middle-age may reflect a shift from bone modeling (formation) in child-
hood and early adulthood to bone remodeling (maintenance). As seen in Fig 1B, degradation
of type I collagen (C1M) is relatively stable throughout the study period. As C1M is a marker
of tissue inflammation and does not represent bone degradation [14], this may explain why
C1M is not age-dependent and PINP is. One may argue that elder subjects have more inflam-
mation than younger, hence a rise in C1M late in life was expected. However, the observed
results may reflect that the elder subjects in this study are “super” healthy compared to the
“normal” elder population.
Type III collagen is one of the main interstitial collagens and structurally similar to type I
collagen. Despite being often associated with type I collagen, the formation of type III collagen
showed a different pattern with an increase in both men and women after age 45–49 and
Fig 3. Type IV collagen turnover as function of age. Biomarkers reflecting degradation and formation of type IV collagen were measured in
serum from 303 healthy men and 314 healthy women aged 22–86 divided into 5-year age groups. (A) Formation of basement membrane type IV
collagen (P4NP7S) and (B) degradation of basement membrane type IV collagen (C4M). Statistical significance of C4M and P4NP7S between
each age group was calculated using ANOVA comparing the mean of each group with the mean of every other group and is presented at the
different age groups in S1 Table. All data are shown as median and interquartile range.
https://doi.org/10.1371/journal.pone.0194458.g003
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Table 3. Sex-specific changes in collagen remodeling.
PINP C1M
Age group Median (men) Median (women) Significant P-value Median (men) Median (women) Significant P-value
20–24 91.8 61.2 Yes 0.02 23.2 28.2 No 0.18
25–29 80.1 53.2 Yes 0.0004 23.0 25.5 No 0.05
30–34 72.9 50.7 Yes 0.001 23.0 25.2 No 0.84
35–39 62.5 35.8 Yes 0.0004 24.6 29.4 No 0.11
40–44 56.3 37.0 Yes 0.001 25.8 20.9 No 0.25
45–49 50.3 38.4 No 0.18 22.0 24.9 No 0.38
50–54 46.7 55.0 No 0.34 22.8 26.0 No 0.82
55–59 44.4 56.2 Yes 0.01 25.6 24.4 No 0.85
60–64 33.2 64.7 Yes <0.0001 25.2 26.1 No 0.66
65–69 36.1 59.9 Yes 0.001 26.5 26.0 No 0.62
70–74 37.3 48.9 No 0.19 27.0 32.4 No 0.27
75–79 44.6 57.4 No 0.10 22.5 26.3 No 0.67
80+ 45.1 62.5 Yes 0.02 26.2 24.4 No 0.90
PRO-C3 C3M
Age group Median (men) Median (women) Significant P-value Median (men) Median (women) Significant P-value
20–24 8.9 9.1 No 0.80 9.9 11.8 No 0.07
25–29 8.3 8.6 No 0.66 9.2 10.8 No 0.21
30–34 7.8 8.9 No 0.85 10.1 9.7 No 0.68
35–39 8.3 8.0 No 0.25 9.4 10.1 No 0.30
40–44 7.6 8.0 No 0.87 8.3 9.1 No 0.33
45–49 7.0 6.8 No 0.94 9.4 9.1 No 0.78
50–54 7.2 7.4 No 0.70 9.6 11.2 No 0.24
55–59 8.2 6.8 Yes 0.03 9.6 11.9 Yes 0.02
60–64 8.7 7.9 No 0.38 9.9 9.4 No 0.49
65–69 7.3 7.2 No 0.31 9.0 9.7 No 0.20
70–74 8.9 7.2 Yes 0.04 9.7 10.1 No 0.25
75–79 9.5 7.6 Yes 0.01 9.3 9.1 No 0.64
80+ 8.9 9.7 No 0.29 10.5 9.7 No 0.34
P4NP7S C4M
Age group Median (men) Median (women) Significant P-value Median (men) Median (women) Significant P-value
20–24 199.5 245.2 No 0.20 15.9 18.4 Yes 0.04
25–29 185.3 210.9 No 0.49 15.5 16.8 No 0.56
30–34 224.9 205.6 No 0.52 17.4 17.6 No 0.89
35–39 182.3 200.8 No 0.27 16.1 19.1 No 0.50
40–44 190.6 193.3 No 0.82 17.6 18.9 No 0.70
45–49 202.5 194.2 No 0.72 18.3 17.5 No 0.36
50–54 212.3 206.8 No 0.77 19.6 20.8 No 0.58
55–59 196.7 230.3 Yes 0.02 17.4 22.6 Yes 0.001
60–64 200.3 225.2 No 0.88 19.5 19.9 No 1.00
65–69 190.7 196.9 No 0.31 19.0 19.5 No 0.25
70–74 199.5 245.2 No 0.20 15.9 18.4 Yes 0.04
75–79 185.3 210.9 No 0.49 15.5 16.8 No 0.56
80+ 224.9 205.6 No 0.52 17.4 17.6 No 0.89
The level of the individual biomarkers between men and women in the five-year age groups was compared using the Mann-Whitney test. P-values are indicated and
represent significant difference (p0.05) between men and women.
https://doi.org/10.1371/journal.pone.0194458.t003
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55–59 respectively. As Pro-C3 is a marker of fibrosis [15,29,42], these results suggest that tissue
fibrosis increases with advancing age.
Type IV collagen is one of the most abundant components of the basement membrane. No
association between age and biomarker level (P4NP7S and C4M) was observed, however C4M
in women was significantly increased with time comparing age 25–29 with age 55–59 (Fig 3B,
S1 Table). These data suggest that basement membrane degradation is increased in the meno-
pausal period.
Karsdal et al.[3] have conducted a study similar to this in rats. They found that type I colla-
gen had an increased turnover in younger rats compared to old rats consistent with our find-
ings. Type III collagen turnover was not significantly influenced by age while type IV collagen
degradation was slightly upregulated in younger animals. These results can be translated into
the present data in humans which is of importance when conducting pre-clinical and clinical
studies in ECM remodeling diseases.
To investigate sex-specific changes in collagen turnover, the level of the individual biomark-
ers between men and women in the five-year age groups was compared. C3M, P4NP7S and
C4M showed a significant difference between men and women in the menopausal period (age
40–60) with women having a higher level of collagen remodeling. PINP and Pro-C3 displayed
an increase in women compared to men in the post-menopausal period (after the age of 60).
PINP showed a significant lower level in women throughout the pre-menopausal period (before
the age of 40). Together, these data suggest that hormonal status might affect collagen remodel-
ing. Whether this is related to estrogen levels or other menopausal mechanisms needs further
investigations. However, the fact that the biomarkers decreases again during the post-meno-
pausal period indicates that a specific event during menopause is somehow influencing the col-
lagen turnover. These sex-specific changes in collagen turnover could be associated with
diseases that is more prevalent in postmenopausal women, as with osteoporosis and PINP [43].
One limitation of this study is the lack of younger subjects. Studies measuring the amino-
terminal pro-peptide of procollagen type III have shown a high level in young children which
decreased with advancing age with a short increase around puberty [38,39]. These data may
reflect the process of modeling where new tissue is being formed during growth whereas the
results of the current study only reflects the end of this process involving a shift towards ECM
remodeling. Another limitation is the lack of information on the subject’s renal function. We
are currently investigating the association between renal function and the collagen turnover
biomarkers. Unpublished data from our group show no association between renal function
and C1M, PINP, C3M, PRO-C3 and C4M.
Subjects with ECM remodeling disorders, such as fibrosis and cancer, have been shown
to have a different ECM turnover compared to healthy individuals [18,22,25,29,33,44] and
attention has been drawn towards the involvement of matrix proteins in ECM remodeling dis-
orders [45,46]. For example in cancer, it is now becoming evident that the tumor milieu, i.e.
the ECM, is just as important as the tumor itself for tumor progression and metastasis [47,48].
The ability to measure changes in ECM turnover in ECM-involved pathologies, could be an
important step towards a better personalized medicine [49,50].
The presented data are important to consider when conducting clinical studies focusing on
ECM-related disorders as these biomarkers have been shown to associate with various connec-
tive tissue disorders where the ECM balance is skewed [5,15,18,22,25,29,33,44].
Conclusions
In conclusion, collagen turnover is affected by age and sex with the interstitial matrix (type I
and III collagen) and the basement membrane (type IV collagen) being differently regulated.
Age-and sex-dependent collagen turnover of the extracellular matrix
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We have established an age- and sex-dependent collagen turnover profile in healthy men and
women and the observed changes needs to be accounted for when measuring ECM related
biomarkers.
Supporting information
S1 Table. Age-related changes in collagen remodeling. Statistical significance (p-value) for
each biomarker calculated using ANOVA comparing the mean of each group with the mean
of every other group. Ns refers to no significance. The following biomarkers showed no signifi-
cance and are therefore not presented: C1M (men), C3M (men), P4NP7S (men and women)
and C4M (men).
(DOCX)
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